Pharmaceutical Policy Experts™

divider

Presentations

Rx|X believes that maintaining an active involvement with the industry through conference participation is critical to staying on top of this ever-changing marketplace and connecting with stakeholders.  Dr. Wallack and Ms. Herzog have presented at several national pharmaceutical policy conferences, listed below.

  • “Vendor Perspectives”, 340B Coalition Annual Winter Conference, San Diego, CA, February 2016.
  • “340B and Specialty Pharmacy,” Therigy Specialty Pharmacy Conference, Orlando, FL, October 2013.
  • “State and Local Governments and 340B,” 340B Coalition Annual Meeting, Washington DC, July 2012.
  • “The 340B Drug Pricing Program:  State Optimization of 340B,” IMS/Data Niche Conference, February 2012.
  • “340B 101” and “History of Average Manufacturer’s Price”, 340B Coalition Annual Winter Meeting, San Diego, CA, February 2012
  • “340B Pricing Primer” and “Impact of the Orphan Drug Exception on Critical Access Hospitals,” 340B Coalition Annual Meeting, Washington DC, July 2011
  • “Demonstrating the Value of the 340B Program to Safety Net Hospitals,” 340B Coalition Conference, July 2011.
  • “Update on the AMP Litigation” and “Enforcement Issues for the 340B Program,” 5th Annual 340B Coalition Winter Conference, Safety Net Hospitals for Pharmaceutical Access, San Diego, CA, February 2009
  • “Extraordinary Drug Price Increases,” Statement before the Joint Economic Committee, Washington, DC, July 2008
  • “Unit of Measure Inconsistencies,” IIR’s Medicaid Drug Rebate Program Conference, September 2007.
  • “The Deficit Reduction Act of 2005:  The Road Ahead for Managed Care,” MedImpact’s Annual Meeting, San Diego, CA, March 2007
  • “PHS Update Panel:  OIG Review of 340B Drug Prices,” DataNiche Associates Fall Medicaid Drug Rebate Meeting, Denver, Colorado, September 2006
  • “Review of 340B Drug Prices,” Keynote Address, Institute for International Research’s annual Medicaid Drug Rebate Program meeting, Chicago, IL, September 2006
  • “Review of 340B Prices,” Texas Association of Community Health Centers, August 2006.
  • “OIG Update:  Review of 340B Drug Prices,” Keynote Address, 340B Coalition Annual Meeting, Washington, DC, July 2006
  • “Recent Enhancements to the HRSA Files and the Implications for All 340B Stakeholders,” DataNiche Associates Spring Medicaid Drug Rebate Meeting, Las Vegas, NV, March 2006
  • “Office of Inspector General Update,” Public Hospital Pharmacy Coalition Meeting, Las Vegas, NV, December 2005
  • “Current Challenges Impacting the PHS 340B Drug Program,” Institute for International Research’s annual Medicaid Drug Rebate Program meeting, Chicago, IL, September 2005
  • “Update from the OIG:  Recent Evaluations of the 340B Program,” DataNiche Associates Fall Medicaid Drug Rebate Meeting, San Francisco, CA, September 2005
  • “Government Agencies and Private Entities: Interdependent Roles in Medicaid and 340B Pricing Enforcement,” Ninth Annual 340B Coalition Conference, Washington, DC, July 2005
  • “Office of Inspector General Update,” Public Hospital Pharmacy Coalition Meeting, Las Vegas, NV, December 2004
  • “An OIG Evaluation of the 340B Drug Pricing Program: Results and Implications for State Medicaid Programs,” DataNiche Associates Fall Medicaid Drug Rebate Meeting, Stone Mountain, GA, September 2004
  • “340B Integrity and Compliance Issues,” Eighth Annual 340B Coalition Conference, Washington, DC, July 2004
  • “340B Pricing Reviews:  The View from the OIG,” 340B Coalition Annual Meeting, Washington, DC, July 2003
  • “How to Avoid Double Discounting Through Cooperation Among HRSA, Medicaid Agencies and Drug Manufacturers,” DataNiche Associates Fall Medicaid Drug Rebate Meeting, Lake Tahoe, NV, September 2001
  • “AIDS Drug Assistance Program Cost Containment Strategies,” 340B Coalition Conference, Washington, DC,           July 2001
  • “Non-FAMP and Other Barriers to 340B Subceiling Prices” and “340B and Medicaid Drug Price Calculations,”  Fifth Annual 340B Coalition Conference, Washington DC, July 2001
  • “Recent OIG Recommendations: AIDS Drug Assistance Program Cost Containment Strategies,” DataNiche Associates Spring Medicaid Drug Rebate Meeting, Orlando, FL, March 2001